# Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

> **NCT06290466** · PHASE1 · COMPLETED · sponsor: **Ahon Pharmaceutical Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** Low dose group
- **DRUG:** High dose group

## Key facts

- **NCT ID:** NCT06290466
- **Lead sponsor:** Ahon Pharmaceutical Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-11
- **Primary completion:** 2023-02-08
- **Final completion:** 2023-02-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06290466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06290466, "Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06290466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*